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Introduction
The infections associated with mechanical ventilation
are a major cause of morbidity and mortality in critically
ill patients. Limited studies report increased mortality
and ICU stay, requirement for mechanical ventilation
and higher costs in ventilator-associated Tracheobron-
chitis (TAV) in comparison to patients with ventilator-
associated pneumonia (NAV). These studies do not
describe the clinical and epidemiological behavior in the
same population as independent entities, so it is neces-
sary to describe the epidemiology of patients with TAV
and NAV.
Methodology
Multicenter cross-sectional study of adult patients who
developed TAV and / or NAV during their stay in the
ICU in 2013 to 2014. Each of the variables was performed
descriptive analysis; to assess differences between the
groups using Chi-square qualitative variables; in continu-
ous variables, t of Student´s have normal distribution;
otherwise the Mann Whitney U test.
Results
Latin Nave collected 147 patients from 6 countries in
Latin America; 63% with NAV and 37% with TAV. The
average age was 51 years; 57% male. The most frequent
comorbidity was cardiovascular (44%) and neurological
(30%), the later higher in TAV (41.5 Vs 23%, p 0.02).
No difference was found in APACHE II at admission,
but the difference appears in SOFA (8 vs. 5, p 0.02).
There were no differences in microbiological isolation,
or bacterial resistance patterns between the two entities.
Greater number of cardiovascular complications and
ARDS were observed in patients with NAV. The ICU
stay, days of mechanical ventilation and mortality were
not different between the two groups.
Conclusions
TAV prevalence was higher than heretofore described in
the literature, indicating that it is considered an indepen-
dent clinical entity. No significant differences were found
in the microbiological isolation, bacterial resistance and
antibiotic therapy used in the two groups, which may sug-
gest that therapeutic approach may be similar to that
recommended for NAV. No differences were observed in
clinical outcomes such as hospital stay, duration of
mechanical ventilation and mortality, although the NAV
was associated with greater proportion of medical
complications.
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